Shin Nippon Biomedical Laboratories (TSE:2395) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:2395 Shin Nippon Biomedical Laboratories Ltd TSE:2395
69 GF Score
Price 円1,470.00
GF Value 円1,745.36
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Shin Nippon Biomedical Laboratories Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

TSE:2395
69GF Score
Shin Nippon Biomedical Laboratories Ltd TSE:2395
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Shin Nippon Biomedical Laboratories (TSE:2395) Overvalued in 2026?

Based on GuruFocus' analysis, Shin Nippon Biomedical Laboratories stock appears to be undervalued. The current stock price of 円1,470.00 is trading 15.8% below its estimated GF Value™ of 円1,745.36. GuruFocus considers Shin Nippon Biomedical Laboratories to be Modestly Undervalued.

Key valuation signals for TSE:2395:

  • Dividends Received:
  • GF Value™: 円1,745.36 vs. price of 円1,470.00 (15.8% below fair value)
  • GF Score™: 69/100 with 5 warning signs

No single metric tells the full story. See the TSE:2395 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shin Nippon Biomedical Laboratories Business Description

Other Exchanges YB3:Germany
Address 8-1 Akashi-cho, Tokyo, JPN
Shin Nippon Biomedical Laboratories Ltd provides pre-clinical testing services in the pharmaceutical industry in Japan. The company provides a range of services such as pre-clinical and analysis studies, contracted clinical trials, SMO, CRO, translational research and cancer treatment.
69GF Score

Get the complete analysis for TSE:2395

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,470.00
Price
円1,745.36
GF Value